RESMED INC (RMD) [Rocket]

In millions, except per share items	Jun-30-23	Jun-30-22	Jun-30-21	Jun-30-20	Jun-30-19	Jun-30-18	Jun-30-17	Jun-30-16
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Sleep and Respiratory Care	3,725.0	3,177.3	2,823.2
Sleep and ‎Respiratory Care	3,725.0	3,177.3	2,823.2	2,602.4
Masks And Other	1,454.3	1,310.4	1,213.2	1,094.6			767.6
Other							1,299.1
Total revenues	4,223.0	3,578.1	3,196.8	2,957.0	2,606.6	2,340.2	2,066.7	1,838.7
Revenue growth [+]	18.0%	11.9%	8.1%	13.4%	11.4%	13.2%	12.4%	9.5%
Sleep and Respiratory Care	17.2%	12.5%
Sleep and ‎Respiratory Care	17.2%	12.5%	8.5%
Masks And Other	11.0%	8.0%	10.8%
Cost of goods sold [+]	1,909.4	1,584.9	1,388.8	1,269.3	1,112.5	1,005.3	911.6	796.1
Cost of product sales								772.2
Amortization of intangibles	42.0	31.1	31.1	30.1			46.6	23.9
Gross profit	2,313.6	1,993.2	1,808.0	1,687.7	1,494.1	1,334.9	1,155.2	1,042.6
Gross margin	54.8%	55.7%	56.6%	57.1%	57.3%	57.0%	55.9%	56.7%
Selling, general and administrative	874.0	737.5	670.4	676.7	914.8	793.1	554.0	488.1
Research and development	287.6	253.6	225.3	201.9			144.5	118.7
Equity in earnings	7.3	8.5	11.2	25.1
Other operating expenses	-50.6	-39.7	-45.1	-49.6	120.8	41.0
EBITDA [+]	1,344.6	1,170.2	1,080.3	989.0	609.2	620.8	568.9	522.7
EBITDA growth	14.9%	8.3%	9.2%	62.3%	-1.9%	9.1%	8.8%	8.4%
EBITDA margin	31.8%	32.7%	33.8%	33.4%	23.4%	26.5%	27.5%	28.4%
Depreciation	134.8	120.0	111.6	105.2	108.3	92.7	112.2	86.8
EBITA	1,209.9	1,050.3	968.7	883.7	500.9	528.1	456.7	435.9
EBITA margin	28.6%	29.4%	30.3%	29.9%	19.2%	22.6%	22.1%	23.7%
Amortization of intangibles	30.4	39.7	45.1	49.6	42.5	27.3
EBIT [+]	1,179.5	1,010.6	923.6	834.1	458.4	500.8	456.7	435.9
EBIT growth	16.7%	9.4%	10.7%	82.0%	-8.5%	9.6%	4.8%	6.5%
EBIT margin	27.9%	28.2%	28.9%	28.2%	17.6%	21.4%	22.1%	23.7%
Non-recurring items [+]	40.4	1.9	8.7	-0.6			30.9	6.9
Restructuring charges	20.1	1.9	8.7				22.4	6.9
Unusual expense	20.2
Legal settlement				-0.6			8.5
Interest expense, net [+]	47.4	22.3	23.6	39.4	-2.3	-16.4	11.2	-5.7
Interest expense	47.4	22.3	23.6	39.4	36.2	28.4	28.2	11.2
Interest income					2.3	16.4	17.1	16.9
Other income (expense), net [+]	9.9	-26.0	-7.6	-62.3	94.3	32.5	4.1	5.0
Other	-5.7	3.2	0.3	2.4			4.1	5.0
Pre-tax income	1,101.7	960.5	883.7	733.1	518.8	521.3	418.7	439.6
Income taxes	204.1	181.0	409.2	111.4	114.3	205.7	76.5	87.2
Tax rate	18.5%	18.8%	46.3%	15.2%	22.0%	39.5%	18.3%	19.8%
Net income	897.6	779.4	474.5	621.7	404.6	315.6	342.3	352.4
Net margin	21.3%	21.8%	14.8%	21.0%	15.5%	13.5%	16.6%	19.2%

Basic EPS [+]	$6.12	$5.34	$3.27	$4.31	$2.83	$2.21	$2.42	$2.51
Growth	14.6%	63.4%	-24.2%	52.3%	27.9%	-8.7%	-3.6%	0.0%
Diluted EPS [+]	$6.09	$5.30	$3.24	$4.27	$2.80	$2.19	$2.40	$2.49
Growth	14.8%	63.6%	-24.1%	52.4%	27.8%	-8.8%	-3.4%	0.6%

Dividends per share [+]	$1.76	$1.68	$1.56	$1.56	$1.48	$1.40	$1.32	$1.20
Growth	4.8%	7.7%	0.0%	5.4%	5.7%	6.1%	10.0%	7.1%

Shares outstanding (basic) [+]	146.8	146.1	145.3	144.3	143.1	142.8	141.4	140.2
Growth	0.5%	0.5%	0.7%	0.9%	0.2%	1.0%	0.8%	-0.2%
Shares outstanding (diluted) [+]	147.5	147.0	146.5	145.7	144.5	144.0	142.5	141.7
Growth	0.3%	0.4%	0.5%	0.8%	0.3%	1.1%	0.6%	-0.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.